| Primary |
| Hepatitis C |
74.8% |
| Drug Use For Unknown Indication |
6.1% |
| Product Used For Unknown Indication |
4.7% |
| Hypertension |
1.9% |
| Epilepsy |
1.7% |
| Oedema |
1.4% |
| Oesophageal Disorder |
1.1% |
| Hepatitis |
1.0% |
| Hepatitis B |
0.8% |
| Pain |
0.8% |
| Hiv Infection |
0.7% |
| Anaemia |
0.6% |
| Chronic Hepatitis C |
0.6% |
| Encephalopathy |
0.6% |
| Hepatitis Viral |
0.6% |
| Infection |
0.6% |
| Magnesium Deficiency |
0.6% |
| Portal Hypertension |
0.6% |
| Prophylaxis |
0.6% |
| Chronic Hepatitis |
0.4% |
|
| Weight Decreased |
13.5% |
| Anaemia |
9.0% |
| Death |
9.0% |
| Lung Disorder |
7.2% |
| Pulmonary Embolism |
6.3% |
| Thrombocytopenia |
5.4% |
| Vomiting |
5.4% |
| Hepatitis C |
4.5% |
| Pyrexia |
4.5% |
| Sudden Death |
4.5% |
| Interstitial Lung Disease |
3.6% |
| Multi-organ Failure |
3.6% |
| Renal Colic |
3.6% |
| Urinary Tract Infection |
3.6% |
| Ascites |
2.7% |
| Aspartate Aminotransferase Increased |
2.7% |
| Gamma-glutamyltransferase Increased |
2.7% |
| Hypertension |
2.7% |
| Liver Disorder |
2.7% |
| Myocarditis |
2.7% |
|
| Secondary |
| Hepatitis C |
58.8% |
| Product Used For Unknown Indication |
10.0% |
| Hiv Infection |
4.9% |
| Anaemia |
3.7% |
| Drug Use For Unknown Indication |
3.2% |
| Hypertension |
2.9% |
| Pain |
2.0% |
| Chronic Hepatitis C |
1.6% |
| Anxiety |
1.5% |
| Depression |
1.5% |
| Oedema |
1.4% |
| Oesophageal Disorder |
1.3% |
| Neutropenia |
1.2% |
| Prophylaxis |
1.2% |
| Hypothyroidism |
1.0% |
| Epilepsy |
0.9% |
| Vitamin Supplementation |
0.9% |
| Oedema Peripheral |
0.8% |
| Encephalopathy |
0.6% |
| Infection |
0.6% |
|
| Anaemia |
14.0% |
| Thrombocytopenia |
13.2% |
| Neutropenia |
7.0% |
| General Physical Health Deterioration |
6.2% |
| Hepatic Neoplasm Malignant |
6.2% |
| Weight Decreased |
5.4% |
| Bone Marrow Failure |
3.9% |
| Hepatic Encephalopathy |
3.9% |
| Lung Disorder |
3.9% |
| Pancytopenia |
3.9% |
| Pruritus |
3.9% |
| Pyrexia |
3.9% |
| Abdominal Pain |
3.1% |
| Asthenia |
3.1% |
| Cardiac Arrest |
3.1% |
| Hepatocellular Carcinoma |
3.1% |
| Pleural Effusion |
3.1% |
| Skull Malformation |
3.1% |
| Thrombotic Thrombocytopenic Purpura |
3.1% |
| Tinnitus |
3.1% |
|
| Concomitant |
| Hepatitis C |
42.6% |
| Chronic Obstructive Pulmonary Disease |
9.6% |
| Pain |
7.4% |
| Product Used For Unknown Indication |
6.4% |
| Hiv Infection |
5.3% |
| Anaemia |
4.3% |
| Dependence |
3.7% |
| Depression |
3.7% |
| Hepatic Cirrhosis |
3.2% |
| Chronic Hepatitis C |
2.1% |
| Ischaemic Cardiomyopathy |
2.1% |
| Diabetes Mellitus |
1.6% |
| Hepatitis C Rna Positive |
1.6% |
| Hypertension |
1.1% |
| Hyperuricaemia |
1.1% |
| Hypothyroidism |
1.1% |
| Peripheral Arterial Occlusive Disease |
1.1% |
| Renal Failure |
1.1% |
| Analgesic Therapy |
0.5% |
| Cardiac Disorder |
0.5% |
|
| Anaemia |
9.4% |
| Pruritus |
9.4% |
| Renal Impairment |
9.4% |
| Flank Pain |
6.3% |
| Haemarthrosis |
6.3% |
| Memory Impairment |
6.3% |
| Rash |
6.3% |
| Retinal Haemorrhage |
6.3% |
| Thrombocytopenia |
6.3% |
| Abdominal Distension |
3.1% |
| Angioedema |
3.1% |
| Blood Creatinine Increased |
3.1% |
| C-reactive Protein Increased |
3.1% |
| Confusional State |
3.1% |
| Electrocardiogram St Segment Elevation |
3.1% |
| Hepatic Neoplasm Malignant Recurrent |
3.1% |
| Hypertriglyceridaemia |
3.1% |
| Lip Oedema |
3.1% |
| Nausea |
3.1% |
| Neuropathy Peripheral |
3.1% |
|
